Opthea stock price
WebMELBOURNE, Australia, March 07, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and... WebApr 14, 2024 · Comparatively, Opthea has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. ... Opthea has a consensus target price of $23.00, indicating a potential upside of ...
Opthea stock price
Did you know?
WebOPT Opthea Ltd. ADR Stock Price & News - WSJ Opthea Ltd. ADR OPT (U.S.: Nasdaq) AT CLOSE 1:53 PM EST 03/01/23 $4.40USD -0.125 -2.76% Volume 4,773 65 Day Avg Vol … WebApr 6, 2024 · Price at close $ 3.5500 0.0200 0.57% Apr 6, 2024 3:39 p.m. EDT About Opthea Ltd. ADR Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological...
WebWhat happened to Opthea Limited’s price movement after its last earnings report? Opthea Limited reported an EPS of -$0.113 in its last earnings report, missing expectations of -$0.013. Following the earnings report the stock price went same 0%. WebAVERAGE : Opthea exhibits an implied growth ratio which is within a 15% range of the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the …
WebMar 17, 2024 · Opthea Ltd (NASDAQ:OPT) $4.32 -0.31 [-6.70%] At close: Mar 17 $4.40 0.0800 [1.85%] PreMarket: 4:55PM EDT Analyst Ratings Earnings Insider Trades Ideas Short Interest Opthea Stock... WebThe current Opthea [ OPT] share price is $4.85. The Score for OPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. OPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels. Will Opthea Stock Go Up Next Year? Data Unavailable Opthea Stock Rating
WebOpthea stock price and OPT stock charts. Free real-time prices, and the most active stock market forums. Opthea (OPT) stock price, charts, trades & the US's most popular … khaite lance ruched cotton topWebOct-20-20 09:38PM. Loss-Making Opthea Limited (ASX:OPT) Expected To Breakeven In The Medium-Term. Simply Wall St. Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering ... khaite knit sweatersWebApr 8, 2024 · What is Opthea's stock price forecast for 2024? 4 equities research analysts have issued twelve-month price objectives for Opthea's shares. Their OPT share price … khaite maddy ribbed-knit sweaterWebOPT Stock Price - Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular khaite leather toteWebIn depth view into Opthea Market Cap including historical data from 2016, charts and stats. Opthea Ltd (OPT) ... Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed ... khaite leather blazerWebMar 22, 2024 · OPTHEA LIMITED (NASDAQ:OPT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share OPTHEA LIMITED Nasdaq: OPT Nasdaq is licorice cookie good crkWebView the latest Opthea Ltd. (OPT) stock price, news, historical charts, analyst ratings and financial information from WSJ. khaite marchio